Mural Oncology's stock plummeted 57% after halting the Phase 3 ARTISTRY-7 trial for nemvaleukin alfa. Click here to read an ...
Pharmaceuticals announced moderated poster presentations of new data from the HELIOS-B Phase 3 clinical trial, which evaluated ...
- XYNGARI™ is the first once-weekly topical product candidate to demonstrate clinical benefit in a Phase 3 clinical trial for moderate-to-severe acne- - Over 30 million acne patients seek ...
X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) is currently evaluating mavorixafor in a Phase 3 clinical trial in chronic neutropenia (CN) patients. The 4WARD trial is expected to enroll a total of 150 ...
The first patient has been dosed in the phase 3 TACTI-004 trial evaluating efti with Keytruda and chemotherapy for advanced ...
3d
Zacks Small Cap Research on MSNIMNN: Protocol in Place for Phase 3 Trial of IMNN-001 in Ovarian Cancer…IMNN READ THE FULL IMNN RESEARCH REPORT Business Update Protocol in Place for Phase 3 Trial of IMNN-001 in Ovarian Cancer On ...
3d
Zacks Small Cap Research on MSNXFOR: Full Enrollment of Phase 3 4WARD Trial Expected in 2H25…XFOR READ THE FULL XFOR RESEARCH REPORT Business Update Full Enrollment of Phase 3 4WARD Trial Expected in 2H25 X4 ...
GSK has reported topline results from a phase 3 trial of its novel antibiotic gepotidacin ... response at the ‘test-of-cure’ clinical visit, which takes place between three and seven days ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results